WC
BMY icon

Waterloo Capital’s Bristol-Myers Squibb BMY Stock Holding History

Waterloo Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$604K Buy
9,966
+3,400
+52% +$198K 0.04% 275
2025
Q4 		$354K Sell
6,566
-2,540
-28% -$122K 0.03% 349
2025
Q3 		$411K Sell
9,106
-10,596
-54% -$495K 0.03% 316
2025
Q2 		$912K Sell
19,702
-30,245
-61% -$1.48M 0.07% 189
2025
Q1 		$3.05M Buy
49,947
+19,376
+63% +$1.13M 0.28% 94
2024
Q4 		$1.73M Buy
30,571
+26,612
+672% +$1.49M 0.18% 124
2024
Q3 		$205K Buy
+3,959
New +$186K 0.02% 343

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Waterloo Capital's BMY Position: Q1 2026 in Review

Waterloo Capital increased its Bristol-Myers Squibb (BMY) stake by 52% in Q1 2026, buying an estimated $198K and bringing the position to 9,966 shares worth $604K. The position accounts for 0.04% of the portfolio, ranked #275.

Waterloo Capital first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.05M in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Waterloo Capital held 9,966 shares of Bristol-Myers Squibb worth $604K as of Q1 2026.
  • Waterloo Capital bought 3,400 Bristol-Myers Squibb shares in Q1 2026, an estimated $198K.
  • Bristol-Myers Squibb made up 0.04% of Waterloo Capital's portfolio in Q1 2026, its #275 holding.
  • Waterloo Capital first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
  • Waterloo Capital's Bristol-Myers Squibb position peaked at $3.05M in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.